Viewing entries in
Sport

Murderball & Cyborgs

I tread very carefully when discussing the use of technology by people with disabilities. I am skeptical of progressive transhumanist arguments associated with reparative technologies. However, this documentary seems to demand that very progressive argument. I am not sure that it lends itself to a cyborgian or posthuman discourse, unless we deal with those terms as simply the broadening of what it means to be human or, indeed, disabled.

I have only seen a trailer for the movie, but the director and actor/athletes talk about transforming the way in which athletes/people with a disability are perceived. In this sense, they are entering into a process of re-definition. I wonder whether they would see themselves as constitutiely technological as athletes. The chairs they use are quite different vehicles/ prosthetics to any that I have seen in other sports and their attitudes come across as deliberately and unapologetically aggresssive.

There is surely a paper waiting to be written about this both within sport studies and cultural studies of technology.

Sport, medicine, ethics, Sweden

Sport Medicine Ethics, 23-24 May, 2005
On Monday 23rd and Tuesday 24th of May 2005, the Stockholm Center for Bioethics, together with the Department of Philosophy at the University of Stockholm and the Oxford Centre for Applied Ethics will organize an international conference on sport medicine ethics, an area still undiscussed within the field of bioethics.

The conference site is Stockholm, and the title of the conference is

"Legitimate and illegitimate enhancements, where to draw the line?".

further details will be posted at the website of the Forum for the Analysis of Sport Technology

Lance Armstrong's LIVESTRONG™

In the summer of 2004, Lance Armstrong worked his fan-base like no other athlete. He returned to competition, after beating testicular cancer and won another Tour de France. He also launched a charity cancer campaign and published another best selling autobiography. I first came across the LIVESTRONG™ campaign in a Nike town store in San Francisco. At the cash register, the LIVESTRONG™ rubber bands were there in handfuls. They cost only $1 and, at that moment, I thought that this seemed to be an interesting initiative: a charity marketed through the celebrity of someone who had all the characteristics of a hero, accompanied by an attention to style. However, I did not purchase one.

Over the course of the summer, LIVESTRONG™ mania caught on around the world. Even a year after they emerged, people can still be seen on the streets wearing them. My next encounter with these rubber bands occurred a month later at the NikeTown store in London, similarly stylish and rubber band aplenty. Accompanying them was a wide range of Lance Armstrong ‘yellow’ clothing. By this point – the end of July – he had won the Tour de France for yet another time. Feeling part of the vibe, I made my purchase proud that I was helping cancer research with my measly £1 (they are a little dearer in the UK, due to the currency conversion). Convincing oneself that cancer research is cool is so much easier when you don’t have to pin a ribbon to your designer jacket, not that I wear such lavish items. But, you see my point; LIVESTRONG™ appeals both on the level of celebrity endorsement and as a sufficiently subtle fashion accessory. Pins are just a little too much of a statement about beliefs, or too much of an inconvenience to wear.

A couple of weeks later, LIVESTRONG™ was most visible from the footage at the Athens 2004 Olympic Games, where a number of athletes wore these rubber bands around their wrists, which surely helped to raise the profile of the campaign. Back in the UK, subsequent weeks would demonstrate the aftermath of LIVESTRONG™. Young children could be seen wearing them, along with a range of similarly coloured counterfeits. The press coverage of LIVESTRONG™ had developed its own momentum. For example, Prince William can be seen wearing the band in a range of photographs about his impending adulthood.

An additional consequence, at least within the UK, has been the emergence of many other kinds of rubber band. We have a blue one that represents a stand against bullying, allegedly prohibited from schools because wearers were bullied! There is also a black and white set of bands – two intertwined – which represents opposition to racism (also a Nike initiative). Most recently, UK Prime Minster Tony Blair has been photographed wearing the ‘Make Poverty History’ blue band. The list goes on, to a point where some schools have banned students from wearing them, because children would have an arm full of rubber bands, which, like jewellery, is seen to be risky to wear in schools

First clone of champion racehorse revealed

New Scientist (among others) recently discussed the work of Italian scientist Cesare Galli, whose cloned horse might begin to cause problems for the world of horse racing:

However, it is not just the sports community that is concerned about this matter:

"William Allen, head of the team at the Equine Research Unit in Newmarket, UK, accuses the government of capitulating to animal welfare groups. Animal Aid, a British-based animal welfare lobby group, opposes cloning of horses on the grounds that cloned embryos are often deformed or grossly over-sized, and so should not be created for what they argue is a leisure activity."

What would be a good reason to clone an animal or a human, if not sport? Perhaps one might suggest that medical research is the only justified context, but only out of necessity. It is not that we want to clone anything at all, but doing so would be incredibly valuable to our understanding of biology and, specifically, disease. Indeed, this is the kind of argument used to defend animal research more broadly. If there were alternative means to advance research, then they would be used. While I don't think this is an adequate position, it might explain why 'leisure' is not important enough.

This news can be traced back to an earlier creation of Galli's team, discussed here:

Galli, C., I. Lagutina, et al. (2003). "A cloned foal born to its dam twin." Nature 424: 635.

The Beam in Your Eye - LASIK

Here is an news article about the use of laser-eye surgery on athletes, in this case the golfer Tiger Woods. The basic premise of this piece is that laser eye surgery is also a performance enhancement for athletes, but it is not banned. why not? "A week ago, Tiger Woods was celebrated for winning golf's biggest tournament, the Masters, with the help of superior vision he acquired through laser surgery." (link)

Here is an extract from an article I have written on this theme, which will be published in a Dutch book on gene doping (edited by Bernike Pasveer and Ivo Van Hilvoorde):

"To articulate the differences between the various uses of medical technology for sport, one can draw three categories of human modification: therapy, non-therapy, and enhancement. To understand the conceptual differences between these categories, it is useful to consider an example of medical intervention where these boundaries appear to be blurred. Laser eye surgery is a medical intervention intended to relieve the deterioration of eyesight. If this technique is applied to someone who has severe or even mild eyesight problems, then it can be considered therapeutic, since it will rectify any imperfection that might inhibit vision. In this capacity, it is tempting (and usual) to describe this as a ‘therapeutic’ medical intervention. It also matters that the definition is underwritten by the existence of a physician’s authority here. Yet, what are the defining characteristics of this ‘therapeutic’ guise? Is it important that the individual’s eyesight is being restored to a previous level of vision? If this were true, then we might wonder about the relevance of this conclusion. How would we feel if the intervention were applied to a person who was born without eyesight? The surgery would not return the individual to any previous state and, in that sense, s(he) would not be restored. In this case, the person would be restored only in the sense that there exists some species-typical state of function, where the treatment is characterised as therapeutic based on some typical functionality that a given species should possess. It could be said that humans have evolved to utilise the capacity for vision. This could also account for an individual who is born with partial vision – for whom we might also argue that restoration to perfect human vision is justified on account of a species-typical level of functioning to which we are comparing the said capability.

Each of these methods of intervention is generally considered acceptable. While there is some disagreement about the legitimacy of interventions that appear to suggest certain ways of being human are preferable over others, let us assume for the moment that eliminating dysfunction, however troubling we might find its definition, is ideologically sound. So, the interest to ensure deafness is corrected is defended on account of it offering an ‘open future’ (Feinberg, 1980), where this entails maximising the possibilities any individual might encounter (for further elaboration see Savulescu, 2001 and Shakespeare, 2001). These examples can be contrasted with an intervention that would raise the level of capability beyond both an individual and species-typical level of normal or even perfect function. So, if laser eye surgery leads to better than perfect vision, we might have quite different concerns and feelings about it.

Yet, it is also possible to think of circumstances where there is not much resistance to such super-human capacities. For example, there do not seem to be particularly strong moral convictions about the use of binoculars, telescopes, magnifying glasses, or even satellites and cameras, which radically re-define our capacity to see beyond our physical constraints. Yet, how would we feel about super-human vision? What if laser eye surgery could enable humans to enjoy the vision of, say, birds of prey. Alternatively, what if it enabled some additional functionality, such as a zoom capability? What should be our moral stance to such modifications and would such modifications be accepted in competitive sporting cultures? (FN: while not specifically tied to a sporting example, ‘super vision’ has been discussed in the context of sport recently (Alderson, 2001))

In the world of sport, the ethical reaction to such innovations would be clearly expressed by a certain moral community, which argues that the ‘natural’ athlete must prevail in sports contests. Where a modification places an athlete over and above their natural level of functioning or some species-typical level of functioning, this constitutes doping and is considered to be unacceptable because it provides an enhancement of the natural. On one level, it is possible to understand why anti-doping exists and why some would seek to justify such rules on the basis of naturalness. In some sports, an athlete with the capacity to ‘zoom’ their vision would be at a considerable advantage to an athlete who does not have such capacity (though in others it might actually be an inconvenience and a skill to be able to modify one’s eyesight to optimise performance). In one very important sense, a contest between two athletes would not be of much interest where one of them has super-vision, since the enhanced athlete will be more successful. However, from another perspective, sport intends to reveal the most capable human. An athlete born with some ‘zoom’ capability is, in one very important sense, the most capable human. Why should an athlete not receive their gold medal, if they are the most capable? These matters raise questions about what is just in sport and the legitimacy of enhanced capabilities."

LifeWaves - Not Doping?

One of the questions at the Harvard symposium was about the ethical status of LifeWaves, the new technology that is designed to boost energy. There is no official WADA position on this one yet, but it is unlikely that it will be considered a method of doping. However ,it is performance enhancing and does offer a 'short-cut' to better performances. To that extent, one might argue (mistakenly) that is compromises the 'spirit of sport'. Here we have a further indication that there is a need for more joined-up thinking in the world of sport, about performance. In a paper I am due to have published in the Journal of Sport Sciences, I argue that it is necessary to ditch the anti-doping framework and replace it with a 'Performance Policy', which makes clear the connections between a range of technologies and how they challenge the ethical status of performance in sport. Here are some details about the LifeWave patches from The California Aggie:

"The product consists of two patches, which the company claims will boost energy by 20 to 40 percent, and contains a vague list of ingredients known as 'orthomolecular compounds.' The NCAA and the U.S. Anti-Doping Agency tested the patches and found no illegal substances. The NCAA went a step further by announcing that the patches do not fall under the category of nutritional substances because nothing is ingested.

While LifeWave's patent is still pending, and no details can be given about the composition of the patches, it is important to note the overall trend that is taking place in sports: an increase in cases of performance-enhancing products or supplements on the market. The fact that athletes at the collegiate and professional levels are looking for any advantages they can gain over their opponents is a distressing sign.

Gone are the days when athletes gained their advantage by just working harder than their competitors. In today's era of sports, money and results are what matter and some athletes seem to be willing to accomplish their goals by any means necessary.

While very few collegiate athletes gain the notoriety that often accompanies professional sports, it is important to note that Davis youths admire UCD athletes. Youngsters often emulate what they see performers doing and it is not far-fetched to believe kids will start using supplements in their adolescent years when given their favorite athletes as examples of a product's success.

LifeWave seems to be the latest in a string of performance-enhancing products. With the rise of such products, athletes are often faced with the tough decision: losing the competitive edge or compromising their athletic integrity."

Of course, I totally reject the stance of this paper, but what's new!?

From BALCO to Bioethics, Harvard

Details of a meeting where I will give a presentation on gene doping: Venue: Boston, USA: E.LaB Event Description

The Harvard Law School Ethics, Law & Biotechnology Society (E.LaB) in conjunction with the Harvard Committee on Sports and Entertainment Law (CSEL) & HL Central are proud to present “From BALCO to Bioethics: The Present and Future of Performance Enhancement in Sport.” The ongoing and highly publicized BALCO controversy has made the topic of performance enhancement among athletes one of substantial current interest and debate. While BALCO controls the headlines of today, and poses difficult questions for professional and amateur sports, we pause to speculate about what the future of performance enhancement in athletics may hold.

This panel discussion will feature Dr. Olivier Rabin, Director of Science for the World Anti-Doping Agency, Dr. Dan Brock, Director of the Division of Medical Ethics at Harvard Medical School, and Dr. Andy Miah, Lecturer in Media, Bioethics and Cyberculture at the University of Paisley, Scotland. The panel will be moderated by Dr. Gil Siegal, visiting professor and Medical Ethics Fellow at Harvard Medical School.

Please join us for an open dialogue about the present and future state of performance enhancement in sport.

Where: Harvard Law School, Langdell South Classroom

When: Monday April 11, 2005. 7-9pm.

Contact: Dan Vorhaus (dvorhaus@law.harvard.edu) for more information.

Marathon Mice and PPARd

Press release from The Salk Institute. It is intriguing that any connection is made between this work and athletic performance. Clearly, the scientist's work is aimed at medical intervention and yet the prospects for athletes are implied through the communication. It is a further indication of how the application of pharmaceuticals to sports is sexy enough to spice up scientific research, but that most scientists are not really alarmed by how their work might be used for non-therapeutic purposes. Equally, perhaps Dr Evans is working with WADA to ensure they have tests for any future product that might arrive on the market. While I don't think that this would be enough to deal with the use of dangerous substances in sport, it would be an important development. Altering steroid receptor genes creates fat burning muscles, resistance to weight gain, and lowered inflammation.

April 04, 2005 La Jalla, CA — The Salk Institute scientist who earlier discovered that enhancing the function of a single protein produced a mouse with an innate resistance to weight gain and the ability to run a mile without stopping, has found new evidence that this protein and a related protein play central roles in the body's complex journey to obesity and offer a new and specific metabolic approach to the treatment of obesity related disease such as Syndrome X (insulin resistance, hyperlipidemia and atherosclerosis).

Dr. Ronald M. Evans, a Howard Hughes Medical Investigator at Salk Institute's Gene Expression Laboratory, presented two new studies Monday, April 4, at Experimental Biology 2005 in the scientific sessions of the American Society for Biochemistry and Molecular Biology.

The studies focus on genes for two of the nuclear hormone receptors that control broad aspects of body physiology, including serving as molecular sensors for numerous fat soluble hormones, Vitamins A and D, and dietary lipids.

The first study focuses on the gene for PPARd, a master regulator that controls the ability of cells to burn fat. When the "delta switch" is turned on in adipose tissue, local metabolism is activated resulting in increased calorie burning. Increasing PPARd activity in muscle produces the "marathon mouse," characterized by super-ability for long distance running.

Marathon mice contain altered muscle composition, which doubles its physical endurance, enabling it to run an hour longer than a normal mouse. Marathon mice contain increased levels of slow twitch (type I) muscle fiber, which confers innate resistance to weight gain, even in the absence of exercise.

Additional work to be reported at Experimental Biology looks at another characteristic of PPARd: its role as a major regulator of inflammation. Coronary artery lesions or atherosclerosis are thought to be sites of inflammation.

Dr. Evans found that activation of PPARd suppresses the inflammatory response in the artery, dramatically slowing down lesion progression. Combining the results of this new study with the original "marathon mouse" findings suggests that PPARd drugs could be effective in controlling atherosclerosis by limiting inflammation and at the same time promoting improved physical performance.

Dr. Evans says he is very excited about the therapeutic possibilities related to activation of the PPARd gene. He believes athletes, especially marathon runners, naturally change their muscle fibers in the same way as seen in the genetically engineered mice, increasing levels of fat-burning muscle fibers and thus building a type of metabolic 'shield" that keeps them from gaining weight even when they are not exercising.

But athletes do it through long periods of intensive training, an approach unavailable to patients whose weight or medical problems prevent them from exercise. Dr. Evans believes activating the PPARd pathway with drugs (one such experimental drug already is in development to treat people with lipid metabolism) or genetic engineering would help enhance muscle strength, combat obesity, and protect against diabetes in these patients.

Link to site

American Academy of Pediatrics on Doping

Today, the AAP published a Policy Statement on the Use of Performance-Enhancing Substances. It dismisses 'scare tactics' of health care professionals, suggesting that denying the performance-enhancing effects of substances to the young athlete is ineffective, as a means of prevention. The pediatrician must 'have an understanding of the incentives for use' and they define the problem as due to the drive for success in our contemporary society.

Of particular interest is that they identify 'limitations of current definitions' of doping, calling for a more restrictive definition that takes into account the possible different kinds of users. Specifically, they want a definitin that protects the most vulnerable kinds of users, in their case, a concern for minors.

They also dismiss the strategy of testing, as a method of prevention, identifying the need for education and evaluation of education programmes, which rarely happens.

Lotions & Potions: The Quest for Performance Enhancement

A symposium at DeSales University in the USA takes place today discussing the use of steroids in sport. It is hosted by the Bioethics Society and offers the following outline. Bioethics Society to discuss steroid use, Tuesday, March 29

"With opening day just around the corner, the U.S. House of Representatives recently took a mighty swing at Major League Baseball's efforts to eradicate steroid use. Another pitch now comes from the Baranzano Society on bioethics. This regional association will sponsor the forum, "Lotions & Potions: The Quest for Performance Enhancement" from 7:30 p.m. to 9:00 p.m. on Tuesday, March 29, in the Labuda Center for the Performing Arts at DeSales. The program will feature a panel of experts in health, science and business, who will discuss the facts and fictions of performance enhancing drugs. The event is open to the public free of charge.

The Congressional hearings shone a national spotlight on baseball players and the prevalence of steroid use in record-breaking performances. Yet use of steroids appears to be rampant, even among amateur athletes and young people, in general. A report from the Centers for Disease Control and Prevention points to a 300 percent increase in the last ten years, with more than 500,000 high school students claiming to have tried steroids.

In addition, according to Rep. Tom Davis, a survey by the National Institute on Drug Abuse and the University of Michigan found that "the perception among high school students that steroids are harmful has dropped from 71 percent in 1992, to 56 percent in 2004." Yet, anabolic steroids are regulated as illegal controlled substances.

During the round table discussion at DeSales, the panel of experts will address the health ramifications, ethical dilemmas, and social consequences of using pharmacological advances to enhance personal performance. The panelists include: Dr. Jay Hoffman, professor of health at The College of New Jersey and vice-president of the National Strength and Conditioning Association, who will report on his meetings with professional baseball coaches during spring training. Also, Richard Bartolacci, founder and president of JBN Enterprises, who will address the issue from the viewpoint of the sports and nutrition supplement industry, and Father Douglas Burns, OSFS, director of the Sport & Exercise Science program at DeSales, who will speak on the subject in terms of sport ethics."

link to site

Bioethics and Human Excellence

Details of a bioethics symposium where performance enhancement makes the programme. Ethics Symposium: Bioethics and Human Excellence Centennial Celebration Event Southwest Missouri State University Friday and Saturday, March 4-5, 2005 Plaster Student Union Theatre

Organized by

College of Humanities and Public Affairs Pamela R. Sailors, Ph.D., Associate Professor and Head, Department of Philosophy Robert P. Jones, Ph.D., Assistant Professor of Religious Studies

Select proceedings being considered for a special edition of Philosophy and Public Affairs

The session on performance and sport included the following papers:

Session II: Bioethics and Human Enhancement: Superior Performance

4:00-6:15 p.m.

Speakers:

Courtney S. Campbell, Ph.D., Professor of Philosophy, Director, Program for Ethics, Science, and the Environment, Oregon State University

Mark A. Holowchak, Ph.D., Professor of Philosophy, Kutztown University, former professional powerlifter

Topics:

Permanent medical implants in the body (bionics)

Sport and the Superior Athlete: Different ways of Enhancing Performance (equipment, training, native powers)

Targeting Specific Deficiencies of Old Age: Muscle Enhancement, Memory Enhancement

Moderator: Jeff Nash, Ph.D., Professor of Sociology, SMSU

link to more info

Genetic tests for Rugby team

Dennis, C. (2005). "Rugby team converts to give gene tests a try." Nature 34: 260. Carina Dennis writes in Nature about an Australian rugby league team which aims to use genetic tests to stream-line training methods. The article quotes someone from the Australian Law Reforms Commission, whose report 'Essentially Yours' deals with this subject at some length. Australia seems to be taking a leading role in thinking through these issues. Ron Trent's work at the University of Sydney is central to this research and he claims that we still do not know enough about genes for this purpose. Issues of privacy and discrimination are central to this topic. Will genetically risky athletes be prevented from participation? Will young children who dont fit the profile be excluded? Will sports authorities have the legal power to demand genetic info from athletes?

'Altitude Chambers' in the JME

This month, the JME includes 3 articles on the ethics of hypoxic training chambers for sport. The lead article by Spriggs disusses the Australian Football League's investigation into the ethical parameters of these 'altitude chambers'. A commentary is then offered by Torbjorn Tannsjo, Claudio Tamburrini and finally by Peter Fricker. Generally, the articles favour enhancement and changing the rules of sport to make enhancement more commonplace.

Why we should allow performance enhancing drugs in sport

Savulescu, Foddy and Clayton author this leader for the British Journal of Sports Medicine. The publication does not say much new to scholars of sport philosophy, though it does make a particular play about the importance of testing for 'health' rather than drugs. Acknowledging the value of the health argument, the authors are interested to see a more permissible culture of drug use in sport. It is important that such arguments are made in this kind of publication by these authors. In the last year or so, bioethical concerns about sport have developed a greater interest in broader bioethical spheres. This article is one contribution that is leading to a steady pace of literature in this subject beyond the sport ethics circles. As an extension of their argument, it is necessary to further question the justification of 'health' as an ethical concern in sport. There is more than one definition of health and the privileged biomedical approach, which continues to undermin anti-doping programmes is not wholly sufficient. Arguably, we have moved beyond using medicine just for therapy and this need not imply any less respect for how it also alleviates human suffering. it is but a further way in which we seek to explore the limits of being human and we have always done this, not even just with technology.

[2007.04.24: By extension, my article with Bengt Kayser and Alex Mauron has just been published by BMC Medical Ethics: 'Current Anti-Doping Policy: A Critical Appraisal (2007)

Boxing and the Medical View

A series of articles in the Journal of Medical Ethics discusses the role of the medical profession in how boxing is administrated. The first is by Sokol who argues that the profession should be limited to providing advice and information about the risks of boxing, rather than to campaign for it to be banned. Perhaps the most interesting article is by Spriggs who discusses the prospect of compulsory genetic tests for boxers as a way of deciding whether they should be granted a license. This matter has been raised elsewhere in the British J of Sports Medicine and in the Australian Law Reforms Commission report, 'Essentially Yours'. Since the significance of such genetic information is widely disputed, its role in determining what kind of sports people can play is certainly controversial.

Posthuman Podiums

Butryn, T. M. (2003). "Posthuman Podiums: Cyborg Narratives of Elite Track and Field Athletes." Sociology of Sport Journal 20: 17-39. Butryn's empirical work on technological narratives is unique. He spends time investigating how athletes articulate their relationship to technology and, while in many instances, they speak about technology as being seamless from the natural sporting body, when it comes to 'body' modification, the distinctions are much clearer. Using performance enhnacements are described by these athletes as contrary to the personal integrity of their performances, though one might beg the question as to whether these views would persist, if it were not for the moral rhetoric that surrounds them.

Gene technology in elite sports, Sweden

International Conference on Gene Technology in Elite Sports,22/23 May, 2003 University of Sports at Stockholm,

The Department of Philosophy at the University of Gothenburg organises an international conference on gene technology in Elite Sports, in collaboration with the University of Sports at Stockholm, and the Center for Sport Studies in Gothenburg. The conference is supported by the Swedish Council of Medicine, section for Medicine.

The following persons have already confirmed their participation: Ruth Chadwick, Julian Savulescu, Torbjörn Tännsjö, Christian Munthe, Sigmund Loland (Norwegian University of Sports), Arne Ljungqvist (Wada and IOC), Bengt Saltin, Lincoln Alison.

For information about the conference, please contact Claudio Tamburrini

The Hastings Center and Sport

The renowned bioethics institute 'The Hastings Center' has been awarded a grant to research 'Ethical, Conceptual & Scientific Issues in the Use of Performance-Enhancing Technologies in Sports'. The funding is provided by the US Anti-Doping Agency and is, to my knowledge, the first study of this kind. Rarely has funding been provided for critical inquiries into the ethical foundation of performance enhancement and sport. The project runs until the end of 2003 and is led by Thomas H. Murray, Erik Parens & Angela Wasunna. link to details